MACOP-B Chemotherapy for the treatment of high grade and intermediate grade Non Hodgkin's lymphoma
β Scribed by Oster, W. ;Forsthuber, T. ;Hennekeuser, H. H. ;Gamm, H. ;Lindemann, A. ;Schmitz, G. ;Fuhr, H. -G. ;Hinterberger, R. ;Kreiter, H. ;Thoenes, W. ;Herrmann, F. ;Mertelsmann, R.
- Publisher
- Springer-Verlag
- Year
- 1990
- Weight
- 643 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
48 patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL) received a CHOP based combination with the addition of etoposide on days 1 and 2, bleomycin days 1 and 10 and methotrexate 1.5 g/m2 on day 10 (MACOBLE). Their median age was 59 years, 20 (42 per cent) had an ECOG performance s
## Abstract NonβHodgkin's lymphoma occurring during pregnancy is a rare event. A young woman at 18 weeks gestation with twins presented with a Bβcell immunoblastic lymphoma. Combination chemotherapy with methotrexate, DO xorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin (MACOPβB)